Shin Kaneko

4.2k total citations · 1 hit paper
68 papers, 2.5k citations indexed

About

Shin Kaneko is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Shin Kaneko has authored 68 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 37 papers in Molecular Biology and 30 papers in Immunology. Recurrent topics in Shin Kaneko's work include CAR-T cell therapy research (43 papers), CRISPR and Genetic Engineering (25 papers) and Pluripotent Stem Cells Research (19 papers). Shin Kaneko is often cited by papers focused on CAR-T cell therapy research (43 papers), CRISPR and Genetic Engineering (25 papers) and Pluripotent Stem Cells Research (19 papers). Shin Kaneko collaborates with scholars based in Japan, United States and China. Shin Kaneko's co-authors include Hiromitsu Nakauchi, Masafumi Onodera, Tatsuki Ueda, Shoichi Iriguchi, Atsushi Suzuki, Hideki Taniguchi, Katashi Fukao, Yun‐Wen Zheng, Bo Wang and Huaigeng Xu and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Shin Kaneko

67 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility

2019 411 citations Huaigeng Xu, Bo Wang et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shin Kaneko Japan	23	1.4k	1.1k	742	441	420	68	2.5k
Carolyn Lutzko United States	27	896 0.6×	403 0.4×	326 0.4×	578 1.3×	410 1.0×	63	2.1k
Yelei Guo China	29	977 0.7×	3.2k 3.0×	1.1k 1.5×	853 1.9×	313 0.7×	38	3.7k
Matus Studeny United States	17	1.2k 0.9×	1.3k 1.2×	259 0.3×	585 1.3×	462 1.1×	37	2.9k
Erika L. Spaeth United States	18	1.6k 1.1×	1.9k 1.8×	602 0.8×	395 0.9×	549 1.3×	33	4.0k
Fernando Anjos‐Afonso United Kingdom	22	998 0.7×	664 0.6×	1.0k 1.4×	245 0.6×	222 0.5×	37	2.6k
Jianyu Weng China	19	836 0.6×	507 0.5×	519 0.7×	118 0.3×	218 0.5×	84	2.1k
Mohammad A. Heidaran United States	27	1.5k 1.1×	475 0.4×	361 0.5×	349 0.8×	208 0.5×	49	2.6k
Lucia Sergi Sergi Italy	19	2.4k 1.8×	1.1k 1.0×	758 1.0×	1.6k 3.5×	125 0.3×	25	3.5k
Ralf Erber Germany	20	1.2k 0.9×	676 0.6×	297 0.4×	87 0.2×	296 0.7×	47	2.5k
Todd Lenvik United States	21	1.3k 0.9×	889 0.8×	1.3k 1.7×	160 0.4×	1.2k 2.9×	37	3.8k

Countries citing papers authored by Shin Kaneko

Since Specialization

Citations

This map shows the geographic impact of Shin Kaneko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin Kaneko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin Kaneko more than expected).

Fields of papers citing papers by Shin Kaneko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shin Kaneko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin Kaneko. The network helps show where Shin Kaneko may publish in the future.

Co-authorship network of co-authors of Shin Kaneko

This figure shows the co-authorship network connecting the top 25 collaborators of Shin Kaneko. A scholar is included among the top collaborators of Shin Kaneko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shin Kaneko. Shin Kaneko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kanie, Keitaro, Takeshi Itoh, Genzo Iguchi, et al.. (2025). Modeling of T cell-mediated autoimmune pituitary disease using human induced pluripotent stem cell-originated organoid. Nature Communications. 16(1). 7900–7900. 1 indexed citations

Mishima, Yuta, Shintaro Okada, Bo Wang, et al.. (2025). Development of chimeric antigen receptor T cells targeting cancer-expressing podocalyxin. Regenerative Therapy. 28. 292–300. 1 indexed citations

Yano, Hisashi, Keiko Koga, Takayuki Sato, et al.. (2024). Human iPSC-derived CD4+ Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft model. Cell stem cell. 31(6). 795–802.e6. 19 indexed citations

Takayanagi, Shin‐ichiro, Bo Wang, Makoto Kakitani, et al.. (2024). A culture method with berbamine, a plant alkaloid, enhances CAR-T cell efficacy through modulating cellular metabolism. Communications Biology. 7(1). 685–685. 3 indexed citations

Gravina, Alessia, Grigol Tediashvili, Kumiko A. Iwabuchi, et al.. (2023). Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity. Cell stem cell. 30(11). 1538–1548.e4. 15 indexed citations

Iriguchi, Shoichi, Yutaka Yasui, Yohei Kawai, et al.. (2021). A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy. Nature Communications. 12(1). 430–430. 149 indexed citations

Iwamoto, Yoshihiro, Masahiro Tanaka, Shoichi Iriguchi, et al.. (2021). Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human disease. Molecular Therapy — Methods & Clinical Development. 21. 262–273. 5 indexed citations

Io, Shingo, Mio Kabata, Katsunori Semi, et al.. (2021). Capturing human trophoblast development with naive pluripotent stem cells in vitro. Cell stem cell. 28(6). 1023–1039.e13. 191 indexed citations

Koga, Keiko, Bo Wang, & Shin Kaneko. (2020). Current status and future perspectives of HLA-edited induced pluripotent stem cells. Inflammation and Regeneration. 40(1). 23–23. 47 indexed citations

10.

Ueda, Tatsuki & Shin Kaneko. (2019). In Vitro Differentiation of T Cell: From CAR-Modified T-iPSC. Methods in molecular biology. 2048. 85–91. 10 indexed citations

11.

Xu, Huaigeng, Bo Wang, Miyuki Ono, et al.. (2019). Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility. Cell stem cell. 24(4). 566–578.e7. 411 indexed citations breakdown →

12.

Iriguchi, Shoichi & Shin Kaneko. (2019). In Vitro Differentiation of T Cells: From Human Embryonic Stem Cells and Induced Pluripotent Stem Cells. Methods in molecular biology. 2048. 59–70. 1 indexed citations

13.

Iriguchi, Shoichi & Shin Kaneko. (2018). Toward the development of true “off‐the‐shelf” synthetic T‐cell immunotherapy. Cancer Science. 110(1). 16–22. 25 indexed citations

14.

Ueda, Norihiro, Yasushi Uemura, Rong Zhang, et al.. (2018). Generation of TCR-Expressing Innate Lymphoid-like Helper Cells that Induce Cytotoxic T Cell-Mediated Anti-leukemic Cell Response. Stem Cell Reports. 10(6). 1935–1946. 20 indexed citations

15.

Minagawa, Atsutaka & Shin Kaneko. (2014). Rise of iPSCs as a cell source for adoptive immunotherapy. Human Cell. 27(2). 47–50. 5 indexed citations

16.

Iriguchi, Shoichi, Norihiro Kikuchi, Shin Kaneko, et al.. (2014). T-cell–restricted T-bet overexpression induces aberrant hematopoiesis of myeloid cells and impairs function of macrophages in the lung. Blood. 125(2). 370–382. 18 indexed citations

17.

Hamanaka, Sanae, Shin Kaneko, Makoto Otsu, et al.. (2008). A new red fluorescent protein that allows efficient marking of murine hematopoietic stem cells. The Journal of Gene Medicine. 10(9). 965–971. 16 indexed citations

18.

Muto, Hideharu, Shin Kaneko, Yasushi Okoshi, et al.. (2007). Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphoma. Journal of Infection and Chemotherapy. 12(6). 391–395. 1 indexed citations

19.

Suzuki, Atsushi, Takao Urabe, Hideki Hayakawa, et al.. (2002). Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein. Journal of Neurochemistry. 82(4). 953–960. 55 indexed citations

20.

Yasukawa, Masaki, Atsuhiko Hasegawa, Ikuya Sakai, et al.. (1999). Down-Regulation of CXCR4 by Human Herpesvirus 6 (HHV-6) and HHV-7. The Journal of Immunology. 162(9). 5417–5422. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact